B cell antibody production is thought to be crucial for protection against virus infection. In this issue of Immunity, Moseman et al. (2012) illustrate an antibody-independent role for B cells in macrophage activation that prevents virus dissemination after subcutaneous infection.
The production of neutralizing antibodies by B cells to protect against viral and bacterial infections is a hallmark of immunity and one of the primary goals of vaccination. However, recent reports including a paper in this issue of Immunity have revealed an additional previously unappreciated critical function of B cells as regulators of innate immunity to virus infection. For some viruses, the very earliest events after infection that lead to virus clearance are not well defined. Whereas pre-existing ''natural'' antibody may in some cases provide some degree of initial protection, the innate immune system including macrophages, NK cells, and neutrophils are believed to be central to limiting initial pathogen spread while the adaptive immune response ramps up. Moreover, cytokines, in particular type I interferons, are key to early protection against virus infection. Thus, in the absence of type I interferon receptor signaling, mice are exquisitely sensitive to infection with a number of viruses including vesicular stomatitis virus (VSV) and mouse cytomegalovirus (MCMV) (García-Sastre and Biron, 2006) . While plasmacytoid dendritic cells (pDCs) triggered through pattern recognition receptors, particularly TLRs, produce copious amounts of IFN-a in response to virus infection, many other cell types also have the ability to produce and respond to type I interferons. Nevertheless, the precise mechanisms by which IFN is induced, especially with regard to the initial cell types that encounter and potentially harbor virus replication, are unclear.
In addition to TLR-mediated IFN-a induction, TLR-independent pathways for driving IFN-a production have also been described (Delale et al., 2005) . For example, the IFN-b response after CMV infection has been shown to be regulated by lymphotoxin (LT) produced by hematopoietic cells. In the absence of LTab-LTbR signaling, mice are highly susceptible to intravenous MCMV infection, resulting in large part from poor induction of type I interferons (Benedict et al., 2001) . Remarkably, the relevant source of LTb is the splenic B cell (Schneider et al., 2008) . Bone marrow chimera reconstitution studies further revealed that the responding cell type is a stromal cell of nonhematopoietic origin. Thus, B cellderived LTb acting on a potentially infected stromal cell drives IFN-b production that leads to early protection against infection. Additionally, this pathway of IFN production is independent of TLR signaling. Considering that these events occur within minutes to a few hours after infection, these studies establish B cells as key regulators of early innate immunity to CMV infection, independent of antibody production.
In the case of vesicular stomatitis virus, a neurotropic member of the Rhabdoviradae family that also includes rabies virus, protection during primary and secondary infections has long been ascribed to early neutralizing natural antibodies followed by induction of VSV-glycoprotein (G)-specific IgM and subsequent class switching leading to IgG production. After intravenous infection, marginal zone metallophilic macrophages (MMM) in the spleen capture the virus (Ciavarra et al., 2005) . This initial line of cellular defense is vital to protection as indicated by the fact that depletion of splenic macrophages results in virus dissemination and lethality (Honke et al., 2012) . B cell-derived LTab is also required for splenic CD169 + macrophage organization (Mebius et al., 2004) , further establishing an antibody-independent role for B cells in antiviral immunity.
More recently, the subcapsular sinus (SCS) macrophages located in lymph nodes (LN) have been shown to be essential for protection against subcutaneous VSV infection. Deletion of the SCS macrophages in the popliteal LN via injection of clodronate-loaded liposomes results in loss of early protection against footpad infection with VSV (Iannacone et al., 2010) . These CD169 + macrophages are the LN counterparts to the splenic CD169 + macrophages. Thus, this macrophage subset represents a critical initial barrier to viral and probably bacterial infection either through hematogenous delivery or through introduction into the skin. But do these cells directly destroy virus or are cooperative efforts needed from other innate and adaptive immune components? In the spleen, CD169 + macrophages actually appear to promote viral replication (Honke et al., 2012) . Splenic CD169 + macrophages selectively express the ubiquitin-specific protease Usp18, which inhibits interferon ab receptor (IFNAR) signaling. This inhibition specifically in the CD169 + macrophages provides a more hospitable environment for VSV replication. In IFNAR-deficient mice, all other splenic macrophage subsets allow VSV replication whereas in normal mice, only the CD169 + macrophages support virus growth. Moreover, deletion of Usp18 results in lower splenic virus titers but rapid dissemination of the virus to the central nervous system. Honke et al. (2012) suggest that uncontrolled virus spread is caused by limited neutralizing antibody production resulting from poor initial virus replication in CD169 + macrophages, which is necessary to promote adaptive immunity. The release of LTa1b2 by B cells allows the CD169 + macrophages to tolerate increased replication of VSV, possibly by inducing Usp18. This increased VSV replication induces the release of type I IFN by the CD169 + macrophages, which in turn prevents the virus from accessing the peripheral nerves and traveling to the CNS by an undefined mechanism. In the absence of B cells there is a lack of LTa1b2 and without this, the virus fails to replicate in the CD169 + macrophages and type I IFN secretion is severely diminished. The lack of type I IFN allows the virus to access the peripheral nerves, leading to dissemination of VSV to the CNS. macrophages warrants analysis. Moseman et al. (2012) go on to show that B cell-derived LTa1b2 is critical for inducing the protective phenotype of the SCS macrophages. When B cells are the only cell type that cannot produce LTa1b2, macrophages are able to capture lymphborne viral particles but the virus does not replicate and type I IFN secretion is compromised. An outstanding question is what factors allow virus replication to proceed-can the effects all be attributed to the inability of SCS macrophages to respond to autocrine as well as perhaps paracrine type I interferon? The study by Moseman et al. (2012) along with other available data suggest the fascinating possibility that the immune system has evolved to allow a certain proscribed degree of microbial growth to ''prime the pump'' in order to promote both rapid innate immunity and provide sufficient antigenic material and inflammatory signals to promote adaptive immunity to prevent entry of pathogens upon secondary encounter. In fact, recent findings indicate that a specialized subset of dendritic cells are permissive for the initial replication of Listeria monocytogenes that leads to the induction of a rapid innate response leading to the generation of a protective T cell response (Edelson et al., 2011) . Additional research will be needed to determine whether events such as these are more commonplace than previously appreciated.
The natural helper (NH) cell comprises a newly identified Th2 cell-type innate lymphocyte population. In this issue of Immunity, Halim et al. (2012) provide evidence that NH cells reside in the lung and play a critical role in protease allergen-induced airway inflammation.
Proteases are important components of many allergens (Reed and Kita, 2004) . For example, papain is a well-known protease that causes occupational asthma, and native papain but not heatinactivated papain induces lung inflammation in mice. House dust mites also produce a well-known allergen whose allergy-inducing ability is largely dependent on its protease activity. In addition, invasion of host tissues by helminthes occurs via high protease activities and helminth infection induces rapid activation of Th2 cell-type inflammatory responses. Proteases are thought to disrupt mucosal integrity by digesting cell adhesion molecules and further act on protease-activated receptors to activate airway epithelial cells. The cytokines thymic stroma lymphopoietin (TSLP), IL-25, and IL-33 derived from epithelial cells activated in this way induce rapid Th2 cell-type inflammation. Polymorphisms of IL-33 and its receptor ST2 are associated with allergic diseases, including asthma in humans, demonstrating the importance of epithelial cellderived cytokines for the onset of Th2 cell-type immune responses.
Papain causes asthma-like symptoms associated with Th2 cell-type reactions such as eosinophilia and goblet cell hyperplasia in Rag-deficient mice. These
